As of Apr 28
| +0.60 / +0.37%|
The 20 analysts offering 12-month price forecasts for Amgen have a median target of 187.00, with a high estimate of 212.00 and a low estimate of 163.00. The median estimate represents a +14.50% increase from the last price of 163.32.
The current consensus among 26 polled investment analysts is to Hold stock in Amgen. This rating has held steady since April, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.